文献速递心外重症与机械循环支持

难治性感染性休克成人的体外生命支持

Extracorporeal life support for adults with refractory septic shock.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-07

回顾性分析71例难治性感染性休克成人接受静脉-动脉体外膜肺氧合(ECMO)的结果,并与253例心源性休克患者对照。感染性休克组成功撤机率15.5%、出院存活率7.0%,均显著低于心源性休克组(45.5% vs 28.9%,P<.001)。ECMO前及后6小时动脉乳酸升高与院内死亡风险相关。

要点

  • 难治性感染性休克成人静脉-动脉ECMO出院存活率仅7.0%。
  • 感染性休克组撤机率15.5%,显著低于心源性休克组的45.5%。
  • ECMO前及后6小时乳酸升高与院内死亡风险相关。

核心结论

  • 难治性感染性休克患者ECMO结果差,存活概率极低,作者对内科难治性感染性休克应用ECMO的效用提出疑问。
  • ECMO前及后6小时动脉乳酸升高与院内死亡风险相关。
  • 作者认为需要进一步大规模研究验证本研究结果。

研究设计与样本

  • 回顾性研究,连续纳入71例难治性感染性休克接受静脉-动脉ECMO的成人患者,并与253例因心源性休克接受静脉-动脉ECMO的对照患者比较。
  • 比较存活者与非存活者的临床参数,并比较两组撤机与存活结局。

主要发现

  • 71例感染性休克患者平均年龄56.0±12.3岁。
  • 11例(15.5%)在中位7.9天(四分位距6.3-10.2天)后成功撤机,其中5例(7.0%)存活至出院。
  • 非存活者ECMO前乳酸为11.6(四分位距7.5-15.0)vs 存活者5.8(四分位距4.3-5.9),P=.036。
  • 非存活者ECMO后6小时乳酸为15.0(四分位距11.1-15.0)vs 存活者5.2(四分位距4.7-5.4),P=.002。
  • 感染性休克组成功撤机率15.5% vs 心源性休克组45.5%,出院存活率7.0% vs 28.9%(n=253,P<.001),感染性休克组均更低。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文指出需要进一步大规模研究验证本研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although the use of extracorporeal membrane oxygenation (ECMO) in shock patients is increasing worldwide, studies concerning this treatment for adult septic shock are limited. This study aimed to analyze the outcome of venoarterial ECMO in adult patients with septic shock refractory to conventional treatment. METHODS: A total of 71 consecutive patients who presented with septic shock and underwent venoarterial ECMO were reviewed. Clinical parameters were compared between survivors and nonsurvivors. Weaning and survival outcomes of these patients were compared with the control group of 253 patients who received venoarterial ECMO for cardiogenic shock. RESULTS: The mean age was 56.0 ± 12.3 years. Of the 71 septic shock patients, 11 (15.5%) were successfully weaned from ECMO after a median of 7.9 [interquartile range (IQR), 6.3-10.2] days, 5 of whom (7.0%) survived to discharge. Pre- and 6 hours post-procedural lactate levels were significantly higher in the nonsurvivors (11.6 [IQR, 7.5-15.0] vs 5.8 [IQR, 4.3-5.9], P = .036; 15.0 [IQR, 11.1-15.0] vs 5.2 [IQR, 4.7-5.4], P = .002). Rates of successful weaning from venoarterial ECMO (15.5% vs 45.5%), and of survival up to hospital discharge (7.0% vs 28.9%) were significantly lower in septic shock than in cardiogenic shock patients (n = 253; P < .001). CONCLUSIONS: Outcomes of ECMO in refractory septic shock patients were poor with a very low probability of survival. This finding raises questions concerning the utility of applying ECMO for medically refractory septic shock. Elevated arterial lactate levels pre- and post-ECMO were associated with risk of in-hospital death. Further large-scale studies are needed to validate the results of this study.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ro SK, Kim WK, Lim JY, et al. Extracorporeal life support for adults with refractory septic shock. J Thorac Cardiovasc Surg. 2018. PMID: 29753504. doi:10.1016/j.jtcvs.2018.03.123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。